Back to Peptide Database
DermatologyResearch Phase

Copper Peptide (Prezatide Copper Acetate)

Overview

Prezatide Copper Acetate is a tripeptide-copper complex, most commonly represented by the sequence Gly-His-Lys bound to a copper ion. Copper peptides are proposed to enhance wound healing, collagen synthesis, and angiogenesis through modulation of matrix metalloproteinases and growth factor activity. The copper moiety is thought to play a critical role in stabilizing the peptide and serving as a cofactor for lysyl oxidase, an enzyme essential for collagen and elastin cross-linking.

Key Research Findings

Preclinical studies in rodent wound models have demonstrated accelerated re-epithelialization and increased tensile strength. Human studies, including small trials in patients with photoaged skin and surgical wounds, have shown improvements in scar appearance and dermal thickness, though large-scale randomized controlled trials are lacking.

Route of Administration

Topical

Regulatory Status

Research Phase

Interested in Copper Peptide (Prezatide Copper Acetate)?

Find a verified provider experienced with Copper Peptide (Prezatide Copper Acetate) protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Copper Peptide (Prezatide Copper Acetate) Provider

Related Peptides

Afamelanotide (Scenesse)

FDA Approved

A synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.

Argireline (Acetyl Hexapeptide-8)

Investigational

Argireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.

Matrixyl (Palmitoyl Pentapeptide-4)

Investigational

Matrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.

Matrixyl 3000

Investigational

Matrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.